secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001193125-23-068406
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia discloses $9.2M total exposure to failed Silicon Valley Bank
-------------------------------------------------------------------

- Approximately $1M in deposit accounts at SVB for daily cash needs as of March 10, 2023.
- Approximately $5.8M in restricted cash in money-market accounts as collateral for office leases and corporate charge card.
- Approximately $2.4M in receivables in a lockbox account at SVB.
- Company states exposure to SVB is limited; total disclosed exposure about $9.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/0001193125-23-068406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312523068406/d409752d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-068406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer